Ownership history in UBS Group AG · 10 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in ARTELO BIOSCIENCES INC (ARTL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 33,621 | +33,412 | +15986.6% | 0.00% | $41K | $3.66 |
| 2025 Q3 | ADDED | 209 | +120 | +134.8% | 0.00% | $959 | $13.77 |
| 2025 Q2 | REDUCED | 89 | -12,683 | -99.3% | 0.00% | $1K | $39.81 |
| 2025 Q1 | REDUCED | 12,772 | -525 | -3.9% | 0.00% | $11K | $15.75 |
| 2024 Q4 | ADDED | 13,297 | +13,172 | +10537.6% | 0.00% | $14K | $19.08 |
| 2024 Q1 | ADDED | 125 | +13 | +11.6% | 0.00% | $185 | $26.64 |
| 2023 Q3 | REDUCED | 112 | -2,266 | -95.3% | 0.00% | $164 | $26.28 |
| 2023 Q1 | REDUCED | 2,378 | -673 | -22.1% | 0.00% | $6K | $41.76 |
| 2022 Q4 | REDUCED | 3,051 | -928 | -23.3% | 0.00% | $9K | $52.02 |
| 2022 Q3 | INITIATED | 3,979 | — | — | 0.00% | $14K | $62.10 |
As of 2025 Q4 — sorted by position size